Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias

NCT02384122 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Angiodysplasia
Vascular Malformations
Gastrointestinal Hemorrhage
Anemia

Interventions

DRUG: Octreotide

Sponsor

Radboud University Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]